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INTRODUCTION the addition of the drug. Concentrations of about
3 µg/ml were required to observe altered cell
morphology. The possibility was considered that
depolymerization of microfilaments-with a re-
sulting change in cell shape and function--resulted
from a rapid depletion of intracellular energy levels
brought about by the inhibition of sugar transport .
The effects of cytochalasin B and iodoacetate on
the adenosine triphosphate (ATP) content of cul-
tured fibroblasts were determined by the luciferase-
luciferin method with a liquid scintillation counter
(9). During a period of 30 min, under conditions in
which the cells became round, cytochalasin B did
not decrease the energy levels of the treated cells .
However, pretreatment with cytochalasin B may
reduce the effects of a 30-min exposure to the
metabolic inhibitor. iodoacetate.
Cytochalasin B, a mold metabolite from Helmin-
thosporium demathioideum, was shown by Carter (1)
to prevent motility and cytokinesis in cultured
cells. This compound has since come into wide
use, and has been shown to affect morphogenic de-
velopment, endocytosis, and intracellular and ex-
tracellular motility (12). Studies with intact cells
indicate that cytochalasin B produces its effect by
depolymerization of cytoplasmic microfilaments.
These microfilaments are considered to be actin-
like. However, recent studies with isolated rabbit
actin have provided conflicting views concerning
the direct effect of the drug on the integrity and
function of these structures (4, 6-8), Kletzien et
al. (5) have observed that cytochalasin B rapidly
and reversibly inhibits glucose and glucosamine
transport. At a concentration of 0 .07 µg/ml, cyto-
chalasin B inhibits 2-deoxyglucose transport by
50%. This inhibition was detected within 2 min of
MATERIALS AND METHODS
Cytochalasin B was made to a 5 mg/ml solution in di-
methyl sulfoxide (DMSO) . A I X 10-3 M standard
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Chemical Co., St. Louis, Mo.) was prepared in Tris
buffer (0.02 M, pH 7.4) and stored at -20°C in
2.0-ml vials. This solution was diluted to 1 X 10-7 M
and contained the same concentration of perchloric
acid as the diluted cell extracts in order to correct the
perchloric anion quenching. Iodoacetate was pur-
chased from Calbiochem (Los Angeles, Calif.) and
made to 0.1 M in H20. All other chemicals were of
reagent grade.
Luciferase Enzyme
Desiccated firefly lantern extract (Sigma Chemical
Co.) was stored at -20 °C. Luciferase enzyme was
prepared for use by reconstituting one vial of extract
with 5.0 ml of 0.05 M MgSO4-0.1 M NaAsO4, pH 7.4
buffer (10). The reconstituted extract was incubated
at 24°C for 4 hr and then centrifuged to remove the
cloudy precipitate . This incubation was necessary in
order to degrade any endogenous ATP. The super-
natant was diluted with 40 volumes of Mgt+-arsenate
buffer before its use in ATP determinations .
Cell Culturing and Treatment
Fertilized chicken eggs were supplied by the Sunny-
side Hatchery of Oregon, Wisconsin. Modified mini-
mal essential medium (Eagle's) was obtained from
Schwarz/Mann (Orangeburg, N. Y.), and fetal calf
serum from Grand Island Biological Co. (Grand
Island, N. Y.) Primary cultures of 12-day-old chick
embryo fibroblasts were prepared by a method des-
cribed by Temin (11). The cells were grown at 37°C
in a humidified CO2 incubator in Eagle's modified
essential medium containing 407 0 fetal calf serum. 5
days later, the fibroblasts were transferred to Falcon
tissue culture dishes (60-mm diameter) (Falcon Plas-
tics, Division of B-D Laboratories, Inc ., Los Angeles,
Calif.) at a concentration of 5 X 10 5 cells per plate.
TABLE I
The Per Cent of ATP Remaining in Cultured Fibroblasts Exposed to Cytochalasin B and
Iodoacetate
The medium used to culture the secondaries contained
47 0 fetal calf serum.
Cells cultured for 1, 2, or 4 days after transfer were
removed from the incubator in groups of three plates .
Each group received one of the treatments outlined
in Table I. A group of three plates, which received no
treatment, served as controls. Three plates of un-
treated cells were trypsinized and the cells counted
with a hemocytometer.
After a specified period of treatment, the plates
were removed from the incubator, the medium was re-
moved, the plates were rinsed with cold 0 .16 M NaCl,
and 2.0 ml of cold 0.4 M HCIO4 was added to extract
the ATP (2). The extraction was carried out for 30
min at 4°C and the extract frozen at -20°C.
Cell Extract Preparation
Frozen perchloric acid cell extracts were thawed,
and samples were diluted with cold distilled water to
bring the ATP concentration within the optimal,
linear range for scintillation counting (1 X 10-9-
1 X 10-8 M ATP). Scintillation vials containing 1 .0
mg of Mg2+-arsenate buffer were placed on ice, and to
each was added, with mixing, 50 µl of diluted cell ex-
tract. The background level of the luciferase and the
standard curves of ATP were determined for each ex-
periment.
Liquid Scintillation Determination
A vial containing unknown, blank, or standard
ATP concentration was removed from the ice . With
mixing, 1 .0 ml of diluted firefly luciferase was added,
and the vial was lowered into the counting chamber.
With experience, the length of time from the addi-
tion of the enzyme to the initiation of the machines'
counting could be maintained at 16 sec. A Packard
model 314 EX liquid scintillation counter was used to
measure the emitted light quanta. The chamber was
maintained at 4°C. Determinations were made with
The calculated means f SE of the per cent ATP remaining after treatment are based
on five to nine experiments (control = 100%) . Student's t with one exception noted
compares the treatment and the control .
* Student's t compares the treatment with 1 .0 mm iodoacetate for 30 min.
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Treatment at 37°C ATP Student's t tot
2 µl/ml DMSO for 30 min 99 .0 t 1 .67 0.289 3 .065
10 µg/ml cytochalasin B for 30 min 101 f 2.26 0 .353 3 .06
1 .0 mm iodoacetate for 30 min 18.2 t 2 .21 45 .4 2 .98
10 µg/ml cytochalasin B for 60 min with 77.2 f 7.62 1 .62 2 .92
1 .0 mm iodoacetate during final 30 min 2 .15* 2 .98the analyzer circuit and with the coincidence switch
off. Voltage was set at 1225 v, and window divisions
were set for a range of 50-1000 on the tritium channel .
The gain setting was 500. The light emissions were
counted for 0.3 min.
Treatment of Data
The mean number of counts for the blanks was sub-
tracted from the values of the unknowns and the
standards. The ATP content of the unknowns was
computed from the standard regression curve . It was
observed that these curves varied with the different
enzyme preparations. The moles of ATP/cell and the
per cent of the untreated cells wre computed for each
treatment. The significance of the data was deter-
mined by Student's t test.
RESULTS AND DISCUSSION
Untreated cultured fibroblasts had a mean ATP
level of 8.09 f 0.52 X 10-15 moles/cell. This level
is similar to that observed by Colby and Edlin,
who, using 32P04 and chromatography, reported
ATP levels of 1 .59 to 2.68 X 10-15 moles/cell in
cultured chick embryo fibroblasts (2). Chapman
et al. (3), using the luciferase-luciferin system, re-
ported ATP levels of 4 .0-8.0 X 10-15 moles/cell in
synchronized cultures of Chinese hamster cells.
The levels of ATP in fibroblasts treated with
DMSO (Student's t value 0.289) and cytochalasin
B (Student's t value 0.353) were not significantly
less than the level in untreated cells (t.ol limit of
3.06) ; this indicates that neither treatment affects
the cells' energy level during 30 min of incubation .
By this time, however, the cells clearly are morpho-
logically altered by cytochalasin B . By Student's
t,01 test, a 30-min exposure to iodoacetate signifi-
cantly reduced the ATP level of the cells to 18 .2 t
2.21 % of the untreated cells without altering cellu-
lar morphology. However, ATP levels of cells
treated with cytochalasin B before exposure to
iodoacetate maintained 77 .2 f 7.62% of the ATP
concentration of untreated cells . Student's t test
indicates that there is a significant difference be-
tween the latter treatment and the iodoacetate
treatment at the t,05 level but not at the t,o1 level.
The loss of iodoacetate's effect after cytochalasin B
treatment may be the result of either a decrease in
cell membrane permeability to iodoacetate or a
change by the cell to an ATP generating pathway
(other than Embden-Meyerhoff) that is insensitive
to this inhibitor.
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These data indicate that the rapid and almost
complete inhibition of glucose transport by cyto-
chalasin B (5) does not result in a detectable de-
crease in the energy levels of the treated cells al-
though they have become round . This rules out
the possibility that depolymerization of cyto-
plasmic microfilaments resulted from a decrease in
cellular ATP. These data support the suggestion
that the drug has a multiplicity of effects . It in-
hibits transport, it alters cell shape, and it may alter
the permeability barrier of the cell surface, as evi-
denced by the reduced effect of iodoacetate after
cytochalasin B pretreatment, on intracellular ATP
levels.
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